1.Philippine guidelines on periodic health examination: Pediatric immunization
Marimel G. Reyes-Pagcatipunan, MD ; Mary Antonette C. Madrid, MD ; Charissa Fay Corazon C. Borja-Tabora, MD ; Carol Stephanie C. Tan-Lim, MD, MSc ; Ian Theodore G. Cabaluna, M.D, GDip, MSc ; Reginald B. Balmeo, MD ; et al.
Pediatric Infectious Disease Society of the Philippines Journal 2023;24(1):176-244
Executive Summary
This Clinical Practice Guideline for the Periodic Health Examination (Pediatric Immunization) is an output from the joint
undertaking of the Department of Health and National Institutes of Health-Institute of Clinical Epidemiology.
This clinical practice guideline is a systematic synthesis of scientific evidence on immunization for the prevention of human
papilloma virus (HPV) infection, influenza, typhoid fever, Japanese encephalitis, poliomyelitis, meningococcal infection, and Hepatitis
A in the pediatric population. The CPG provides nine (9) recommendations on prioritized questions regarding the relevant vaccines
for preventing these seven (7) diseases.
Recommendations are based on the appraisal of the best available evidence on each of the eight identified clinical
questions. The CPG is intended to be used by general practitioners and specialists in the primary care setting, policy makers,
employers and administrators, allied health practitioners and even patients. The guideline development process followed the widely
accepted Grading of Recommendations, Assessment, Development, and Evaluation or the GRADE approach including GRADE
Adolopment, a systematic process of adapting evidence summaries and the GRADE Evidence to Decision (EtD) framework. 1,2 It
includes 1) identification of critical questions and critical outcomes, 2) retrieval of current evidence, 3) assessment and synthesis of
the evidence base for these critical questions, 4) formulation of draft recommendations, 5) convening of a multi-sectoral stakeholder
panel to discuss values and preferences and assess the strength of the recommendations, and 6) planning for dissemination,
implementation, impact evaluation and updating.
The recommendations in this CPG shall hold and will be updated after 3 years or when new evidence arise.
2.Clinical practice guidelines on leptospirosis in children 2019
Maria Anna P. Bañ ; ez, M.D ; Melba V. Marasigan, M.D. ; Ma. Liza Antoinette M. Gonzales, M.D., MSc ; Grace Devota G. Go, M.D. ; Fatima I. Gimenez, M.D. ; Mary Antonette C. Madrid, M.D. ; John Andrew T. Camposano, M.D. ; Jennifer M. Nailes, M.D., MSPH ; Ma. Lucila M. Perez, M.D., MSc
Pediatric Infectious Disease Society of the Philippines Journal 2023;24(1):5-69
Executive Summary
Leptospirosis is a disease prevalent mostly in tropical and subtropical countries. Its potential to be a concerning
problem emerges with the onset of the rainy season, as flooding and heavy rainfall facilitate disease epidemics. Among
those at risk of contracting the disease are field workers, veterinarians, sewer workers, military personnel and those
who swim or wade in contaminated waters.
In the absence of an existing evidence-based guideline for the pediatric age group, this first edition hopes to
standardize approach to diagnosis, antibiotic management, and prevention of leptospirosis. The intended users are
primary care physicians, family medicine physicians, pediatricians, and other healthcare workers involved in the
management of leptospirosis in children.
Ten priority questions were identified by a group of experts composed of an oversight committee, a guideline
writing panel, and a technical review committee. The GRADE methodology was used to determine the quality of
evidence of each recommendation. The draft recommendations (summarized below) were finalized after these were
presented to and voted on by a panel of stakeholders.